Total Payments
$491,079
2024 Payments
$81,084
Companies
58
Transactions
1,694
Medicare Patients
3,871
Medicare Billing
$373,781
Payment Breakdown by Category
Other$440,150 (89.6%)
Food & Beverage$20,412 (4.2%)
Consulting$16,331 (3.3%)
Travel$14,058 (2.9%)
Education$127.41 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $440,150 | 481 | 89.6% |
| Food and Beverage | $20,412 | 1,023 | 4.2% |
| Consulting Fee | $16,331 | 8 | 3.3% |
| Travel and Lodging | $14,058 | 170 | 2.9% |
| Education | $127.41 | 12 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $391,007 | 836 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $75,423 | 171 | $0 (2023) |
| AbbVie Inc. | $15,054 | 83 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $957.70 | 54 | $0 (2022) |
| Novo Nordisk Inc | $892.12 | 92 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $853.67 | 57 | $0 (2023) |
| Dexcom, Inc. | $589.88 | 34 | $0 (2023) |
| Corcept Therapeutics | $575.38 | 33 | $0 (2022) |
| Insulet Corporation | $434.89 | 21 | $0 (2023) |
| Amgen Inc. | $371.94 | 23 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $81,084 | 161 | Lilly USA, LLC ($81,084) |
| 2023 | $56,286 | 161 | Lilly USA, LLC ($53,174) |
| 2022 | $69,042 | 197 | Lilly USA, LLC ($65,284) |
| 2021 | $39,401 | 209 | Lilly USA, LLC ($33,378) |
| 2020 | $51,402 | 176 | Lilly USA, LLC ($40,213) |
| 2019 | $76,065 | 288 | Lilly USA, LLC ($50,698) |
| 2018 | $71,318 | 252 | Lilly USA, LLC ($36,861) |
| 2017 | $46,481 | 250 | Lilly USA, LLC ($30,314) |
All Payment Transactions
1,694 individual payment records from CMS Open Payments — Page 1 of 68
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $525.00 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Travel and Lodging | Cash or cash equivalent | $16.08 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Travel and Lodging | Cash or cash equivalent | $42.88 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $875.00 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $525.00 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Travel and Lodging | Cash or cash equivalent | $58.96 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Travel and Lodging | Cash or cash equivalent | $10.32 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $525.00 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Travel and Lodging | Cash or cash equivalent | $77.72 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $875.00 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Travel and Lodging | Cash or cash equivalent | $38.86 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $525.00 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Travel and Lodging | Cash or cash equivalent | $36.18 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,004 | 1,314 | $233,018 | $94,116 |
| 2022 | 8 | 959 | 1,253 | $225,354 | $94,763 |
| 2021 | 8 | 964 | 1,291 | $235,353 | $99,326 |
| 2020 | 9 | 944 | 1,249 | $228,674 | $85,577 |
Total Patients
3,871
Total Services
5,107
Medicare Billing
$373,781
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 396 | 597 | $111,042 | $49,615 | 44.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 216 | 222 | $48,840 | $15,012 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 167 | 196 | $24,500 | $11,679 | 47.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $22,594 | $9,119 | 40.4% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 35 | 39 | $10,608 | $3,877 | 36.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $5,704 | $2,308 | 40.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 29 | 70 | $6,930 | $1,753 | 25.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 51 | 80 | $2,800 | $752.08 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 390 | 590 | $109,526 | $50,009 | 45.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 203 | 208 | $45,760 | $15,592 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 99 | 99 | $28,314 | $11,289 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 143 | 170 | $21,226 | $10,771 | 50.7% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 31 | 31 | $8,432 | $3,230 | 38.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $3,496 | $1,609 | 46.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 26 | 60 | $5,940 | $1,535 | 25.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 48 | 76 | $2,660 | $728.76 | 27.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 376 | 605 | $111,320 | $50,729 | 45.6% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 190 | 200 | $44,000 | $15,339 | 34.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 125 | 125 | $35,750 | $14,519 | 40.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 143 | 174 | $21,576 | $11,007 | 51.0% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2021 | 36 | 37 | $10,064 | $3,398 | 33.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 29 | 29 | $5,336 | $2,398 | 44.9% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 18 | 48 | $4,752 | $1,232 | 25.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 47 | 73 | $2,555 | $703.92 | 27.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 370 | 604 | $111,136 | $42,336 | 38.1% |
About Dr. Cory White, MD
Dr. Cory White, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700973765.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cory White, MD has received a total of $491,079 in payments from pharmaceutical and medical device companies, with $81,084 received in 2024. These payments were reported across 1,694 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($440,150).
As a Medicare-enrolled provider, White has provided services to 3,871 Medicare beneficiaries, totaling 5,107 services with total Medicare billing of $373,781. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Greenville, SC
- Active Since 10/09/2006
- Last Updated 04/19/2018
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1700973765
Products in Payments
- MOUNJARO (Drug) $168,346
- TRULICITY (Drug) $167,466
- JARDIANCE (Drug) $124,527
- Androgel (Drug) $10,320
- Synthroid (Drug) $2,403
- SYNTHROID (Drug) $1,074
- FARXIGA (Drug) $957.70
- HUMULIN (Drug) $639.03
- Korlym (Drug) $575.38
- Omnipod (Device) $434.89
- Victoza (Drug) $363.22
- Vascepa (Drug) $358.20
- Ozempic (Drug) $300.94
- BAQSIMI (Drug) $297.66
- AFREZZA (Drug) $287.84
- TRADJENTA (Drug) $266.01
- TOUJEO (Drug) $263.29
- UNITHROID (Drug) $258.30
- Repatha (Biological) $247.00
- TEPEZZA (Drug) $246.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Greenville
Mark Warren, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.3M
Endocrinology, Diabetes & Metabolism $1.3M
Dr. James Horton, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $151,082
Endocrinology, Diabetes & Metabolism $151,082
Dr. Regina Dodis, D. O, D. O
Endocrinology, Diabetes & Metabolism — Payments: $11,168
Endocrinology, Diabetes & Metabolism $11,168
Sandra Weber, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $7,533
Endocrinology, Diabetes & Metabolism $7,533
Mojgan Rahmani, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $6,663
Endocrinology, Diabetes & Metabolism $6,663
John Bruch, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $3,981
Endocrinology, Diabetes & Metabolism $3,981